Travere Therapeutics Reports Third Quarter 2023 Financial Results
SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its third quarter 2023 financial results and provided a corporate update.
View Full Press Release